English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 118 | Tables: 114 | Pharma & Healthcare
The global market for Pain Therapeutic Solutions was valued at US$ 77860 million in the year 2024 and is projected to reach a revised size of US$ 103427 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Pain Therapeutic Solutions encompass an integrated portfolio of medicines, devices, minimally invasive interventions, and digital therapeutics for acute and chronic pain management. Core elements include small-molecule and biologic analgesics, non-addictive novel pain medications, neuromodulation and spinal cord stimulation devices, remote-monitoring and follow-up digital health tools, and multidisciplinary care pathways. With a rising prevalence of chronic pain, increasing complexity of postoperative and cancer-related pain, and stronger demand for safe, personalized approaches, the field is shifting from single-product supply toward combined therapy–device–data solutions—creating broad commercial and partnership opportunities for hospitals, pharma and device manufacturers, and digital-health providers.
Opportunities for Pain Therapeutic Solutions are driven by a combination of policy and technology trends: governmental and regulatory efforts to optimize analgesic management and curb opioid misuse are prompting healthcare systems to seek alternative, integrated solutions; pharmaceutical and device companies’ continued investment in R&D, M&A and strategic partnerships is accelerating clinical translation of novel analgesics, neuromodulation devices and minimally invasive interventions; concurrently, maturation of digital therapeutics and remote-follow-up platforms enables scalable personalized pain management and longitudinal outcome monitoring, attracting investor interest. Patient expectations for quality of life and the adoption of multidisciplinary pain-management models are shifting care from episodic symptom relief to continuous, patient-centered management—creating a commercial loop spanning hospitals, community care, pharmaceuticals, devices and services.
The sector faces regulatory constraints and commercialization hurdles. Strict prescribing guidance (especially for opioids) helps safeguard patients but raises compliance costs for clinical trials and market entry; high R&D and device investment, together with the need for operator training and multidisciplinary coordination, create adoption barriers for smaller institutions; heterogeneity in reimbursement and pricing across health systems affects scale-up speed for innovative solutions; meanwhile, competition from non-pharmacologic therapies (e.g., physical therapy, behavioral interventions) requires solution providers to demonstrate durable clinical and economic advantages to gain clinical and payer acceptance.
Downstream demand favors multi-indication, clinically meaningful, and patient-experience–driven solutions: oncology pain, postoperative analgesia, chronic low back pain and neuropathic pain are major clinical use-cases pulling integrated offerings into hospitals and specialty clinics, which prefer solutions yielding rapid relief and easy follow-up. Pharmaceutical companies increasingly design R&D programs that link drugs with devices, companion diagnostics and digital tools to enhance clinical utility. Payers and health systems’ focus on long-term adherence and readmission rates favors solutions demonstrating real-world benefits, while rising patient acceptance of non-addictive, low-side-effect therapies is driving product and service design around patient-reported outcomes.
Upstream, drug-based solutions rely on high-quality APIs, formulation excipients and GMP manufacturing; device-based solutions depend on precision electronic components, implantable materials, medical-grade manufacturing and integration of device software with digital platforms. Supply-chain stability, regulatory certification of critical suppliers, and continuous availability of reagents and standards are foundational to clinical continuity and product consistency. Large-company annual reports commonly identify supplier concentration and compliance risk as material business risks, underscoring that growth must be matched by resilient procurement and quality systems; while local manufacturing and domestic substitution are strengthening supply for certain consumables, high-end device components and biopharmaceutical-grade materials remain globally concentrated—posing real scalability requirements for new entrants.
This report aims to provide a comprehensive presentation of the global market for Pain Therapeutic Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Therapeutic Solutions.
The Pain Therapeutic Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pain Therapeutic Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Therapeutic Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Cadila Pharmaceuticals
GSK
Abbott Laboratories
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Medtronic
Boston Scientific
Abbott
OMRON
Segment by Type
Drugs
Medical Devices
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Therapeutic Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Therapeutic Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Medical Devices
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pain Therapeutic Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Therapeutic Solutions Market Perspective (2020-2031)
2.2 Global Pain Therapeutic Solutions Growth Trends by Region
2.2.1 Global Pain Therapeutic Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pain Therapeutic Solutions Historic Market Size by Region (2020-2025)
2.2.3 Pain Therapeutic Solutions Forecasted Market Size by Region (2026-2031)
2.3 Pain Therapeutic Solutions Market Dynamics
2.3.1 Pain Therapeutic Solutions Industry Trends
2.3.2 Pain Therapeutic Solutions Market Drivers
2.3.3 Pain Therapeutic Solutions Market Challenges
2.3.4 Pain Therapeutic Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Therapeutic Solutions Players by Revenue
3.1.1 Global Top Pain Therapeutic Solutions Players by Revenue (2020-2025)
3.1.2 Global Pain Therapeutic Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Top Pain Therapeutic Solutions Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pain Therapeutic Solutions Revenue
3.4 Global Pain Therapeutic Solutions Market Concentration Ratio
3.4.1 Global Pain Therapeutic Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Therapeutic Solutions Revenue in 2024
3.5 Global Key Players of Pain Therapeutic Solutions Head office and Area Served
3.6 Global Key Players of Pain Therapeutic Solutions, Product and Application
3.7 Global Key Players of Pain Therapeutic Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Therapeutic Solutions Breakdown Data by Type
4.1 Global Pain Therapeutic Solutions Historic Market Size by Type (2020-2025)
4.2 Global Pain Therapeutic Solutions Forecasted Market Size by Type (2026-2031)
5 Pain Therapeutic Solutions Breakdown Data by Application
5.1 Global Pain Therapeutic Solutions Historic Market Size by Application (2020-2025)
5.2 Global Pain Therapeutic Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pain Therapeutic Solutions Market Size (2020-2031)
6.2 North America Pain Therapeutic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pain Therapeutic Solutions Market Size by Country (2020-2025)
6.4 North America Pain Therapeutic Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Therapeutic Solutions Market Size (2020-2031)
7.2 Europe Pain Therapeutic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pain Therapeutic Solutions Market Size by Country (2020-2025)
7.4 Europe Pain Therapeutic Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pain Therapeutic Solutions Market Size (2020-2031)
8.2 Asia-Pacific Pain Therapeutic Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pain Therapeutic Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Pain Therapeutic Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pain Therapeutic Solutions Market Size (2020-2031)
9.2 Latin America Pain Therapeutic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pain Therapeutic Solutions Market Size by Country (2020-2025)
9.4 Latin America Pain Therapeutic Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Therapeutic Solutions Market Size (2020-2031)
10.2 Middle East & Africa Pain Therapeutic Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pain Therapeutic Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Pain Therapeutic Solutions Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Pain Therapeutic Solutions Introduction
11.1.4 AbbVie Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Bristol Myers Squibb Co.
11.2.1 Bristol Myers Squibb Co. Company Details
11.2.2 Bristol Myers Squibb Co. Business Overview
11.2.3 Bristol Myers Squibb Co. Pain Therapeutic Solutions Introduction
11.2.4 Bristol Myers Squibb Co. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.2.5 Bristol Myers Squibb Co. Recent Development
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Details
11.3.2 Sanofi S.A. Business Overview
11.3.3 Sanofi S.A. Pain Therapeutic Solutions Introduction
11.3.4 Sanofi S.A. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.3.5 Sanofi S.A. Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Details
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Pain Therapeutic Solutions Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Pain Therapeutic Solutions Introduction
11.5.4 Pfizer Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.5.5 Pfizer Inc. Recent Development
11.6 Cadila Pharmaceuticals
11.6.1 Cadila Pharmaceuticals Company Details
11.6.2 Cadila Pharmaceuticals Business Overview
11.6.3 Cadila Pharmaceuticals Pain Therapeutic Solutions Introduction
11.6.4 Cadila Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.6.5 Cadila Pharmaceuticals Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Pain Therapeutic Solutions Introduction
11.7.4 GSK Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Pain Therapeutic Solutions Introduction
11.8.4 Abbott Laboratories Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Pain Therapeutic Solutions Introduction
11.9.4 Novartis AG Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
11.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
11.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
11.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pain Therapeutic Solutions Introduction
11.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
11.11 Sun Pharmaceutical Industries Ltd.
11.11.1 Sun Pharmaceutical Industries Ltd. Company Details
11.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd. Pain Therapeutic Solutions Introduction
11.11.4 Sun Pharmaceutical Industries Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.12 Teva Pharmaceuticals Ltd.
11.12.1 Teva Pharmaceuticals Ltd. Company Details
11.12.2 Teva Pharmaceuticals Ltd. Business Overview
11.12.3 Teva Pharmaceuticals Ltd. Pain Therapeutic Solutions Introduction
11.12.4 Teva Pharmaceuticals Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.12.5 Teva Pharmaceuticals Ltd. Recent Development
11.13 Mallinckrodt Pharmaceuticals
11.13.1 Mallinckrodt Pharmaceuticals Company Details
11.13.2 Mallinckrodt Pharmaceuticals Business Overview
11.13.3 Mallinckrodt Pharmaceuticals Pain Therapeutic Solutions Introduction
11.13.4 Mallinckrodt Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.13.5 Mallinckrodt Pharmaceuticals Recent Development
11.14 Endo Pharmaceuticals Inc.
11.14.1 Endo Pharmaceuticals Inc. Company Details
11.14.2 Endo Pharmaceuticals Inc. Business Overview
11.14.3 Endo Pharmaceuticals Inc. Pain Therapeutic Solutions Introduction
11.14.4 Endo Pharmaceuticals Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.14.5 Endo Pharmaceuticals Inc. Recent Development
11.15 Bayer AG
11.15.1 Bayer AG Company Details
11.15.2 Bayer AG Business Overview
11.15.3 Bayer AG Pain Therapeutic Solutions Introduction
11.15.4 Bayer AG Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.15.5 Bayer AG Recent Development
11.16 F. Hoffmann-La Roche Ltd.
11.16.1 F. Hoffmann-La Roche Ltd. Company Details
11.16.2 F. Hoffmann-La Roche Ltd. Business Overview
11.16.3 F. Hoffmann-La Roche Ltd. Pain Therapeutic Solutions Introduction
11.16.4 F. Hoffmann-La Roche Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.16.5 F. Hoffmann-La Roche Ltd. Recent Development
11.17 Procter & Gamble
11.17.1 Procter & Gamble Company Details
11.17.2 Procter & Gamble Business Overview
11.17.3 Procter & Gamble Pain Therapeutic Solutions Introduction
11.17.4 Procter & Gamble Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.17.5 Procter & Gamble Recent Development
11.18 AstraZeneca
11.18.1 AstraZeneca Company Details
11.18.2 AstraZeneca Business Overview
11.18.3 AstraZeneca Pain Therapeutic Solutions Introduction
11.18.4 AstraZeneca Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.18.5 AstraZeneca Recent Development
11.19 Cardinal Health
11.19.1 Cardinal Health Company Details
11.19.2 Cardinal Health Business Overview
11.19.3 Cardinal Health Pain Therapeutic Solutions Introduction
11.19.4 Cardinal Health Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.19.5 Cardinal Health Recent Development
11.20 Perrigo Company Plc.
11.20.1 Perrigo Company Plc. Company Details
11.20.2 Perrigo Company Plc. Business Overview
11.20.3 Perrigo Company Plc. Pain Therapeutic Solutions Introduction
11.20.4 Perrigo Company Plc. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.20.5 Perrigo Company Plc. Recent Development
11.21 Bausch Health Companies Inc.
11.21.1 Bausch Health Companies Inc. Company Details
11.21.2 Bausch Health Companies Inc. Business Overview
11.21.3 Bausch Health Companies Inc. Pain Therapeutic Solutions Introduction
11.21.4 Bausch Health Companies Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.21.5 Bausch Health Companies Inc. Recent Development
11.22 Viatris
11.22.1 Viatris Company Details
11.22.2 Viatris Business Overview
11.22.3 Viatris Pain Therapeutic Solutions Introduction
11.22.4 Viatris Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.22.5 Viatris Recent Development
11.23 Amneal Pharmaceuticals
11.23.1 Amneal Pharmaceuticals Company Details
11.23.2 Amneal Pharmaceuticals Business Overview
11.23.3 Amneal Pharmaceuticals Pain Therapeutic Solutions Introduction
11.23.4 Amneal Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.23.5 Amneal Pharmaceuticals Recent Development
11.24 Purdue Pharmaceuticals L.P.
11.24.1 Purdue Pharmaceuticals L.P. Company Details
11.24.2 Purdue Pharmaceuticals L.P. Business Overview
11.24.3 Purdue Pharmaceuticals L.P. Pain Therapeutic Solutions Introduction
11.24.4 Purdue Pharmaceuticals L.P. Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.24.5 Purdue Pharmaceuticals L.P. Recent Development
11.25 Medtronic
11.25.1 Medtronic Company Details
11.25.2 Medtronic Business Overview
11.25.3 Medtronic Pain Therapeutic Solutions Introduction
11.25.4 Medtronic Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.25.5 Medtronic Recent Development
11.26 Boston Scientific
11.26.1 Boston Scientific Company Details
11.26.2 Boston Scientific Business Overview
11.26.3 Boston Scientific Pain Therapeutic Solutions Introduction
11.26.4 Boston Scientific Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.26.5 Boston Scientific Recent Development
11.27 Abbott
11.27.1 Abbott Company Details
11.27.2 Abbott Business Overview
11.27.3 Abbott Pain Therapeutic Solutions Introduction
11.27.4 Abbott Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.27.5 Abbott Recent Development
11.28 OMRON
11.28.1 OMRON Company Details
11.28.2 OMRON Business Overview
11.28.3 OMRON Pain Therapeutic Solutions Introduction
11.28.4 OMRON Revenue in Pain Therapeutic Solutions Business (2020-2025)
11.28.5 OMRON Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pain Therapeutic Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Medical Devices
Table 4. Key Players of Others
Table 5. Global Pain Therapeutic Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pain Therapeutic Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pain Therapeutic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pain Therapeutic Solutions Market Share by Region (2020-2025)
Table 9. Global Pain Therapeutic Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pain Therapeutic Solutions Market Share by Region (2026-2031)
Table 11. Pain Therapeutic Solutions Market Trends
Table 12. Pain Therapeutic Solutions Market Drivers
Table 13. Pain Therapeutic Solutions Market Challenges
Table 14. Pain Therapeutic Solutions Market Restraints
Table 15. Global Pain Therapeutic Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pain Therapeutic Solutions Market Share by Players (2020-2025)
Table 17. Global Top Pain Therapeutic Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Therapeutic Solutions as of 2024)
Table 18. Ranking of Global Top Pain Therapeutic Solutions Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pain Therapeutic Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pain Therapeutic Solutions, Headquarters and Area Served
Table 21. Global Key Players of Pain Therapeutic Solutions, Product and Application
Table 22. Global Key Players of Pain Therapeutic Solutions, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pain Therapeutic Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pain Therapeutic Solutions Revenue Market Share by Type (2020-2025)
Table 26. Global Pain Therapeutic Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pain Therapeutic Solutions Revenue Market Share by Type (2026-2031)
Table 28. Global Pain Therapeutic Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pain Therapeutic Solutions Revenue Market Share by Application (2020-2025)
Table 30. Global Pain Therapeutic Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pain Therapeutic Solutions Revenue Market Share by Application (2026-2031)
Table 32. North America Pain Therapeutic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pain Therapeutic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pain Therapeutic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pain Therapeutic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pain Therapeutic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pain Therapeutic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pain Therapeutic Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pain Therapeutic Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pain Therapeutic Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pain Therapeutic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pain Therapeutic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pain Therapeutic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pain Therapeutic Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pain Therapeutic Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pain Therapeutic Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 47. AbbVie Company Details
Table 48. AbbVie Business Overview
Table 49. AbbVie Pain Therapeutic Solutions Product
Table 50. AbbVie Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Bristol Myers Squibb Co. Company Details
Table 53. Bristol Myers Squibb Co. Business Overview
Table 54. Bristol Myers Squibb Co. Pain Therapeutic Solutions Product
Table 55. Bristol Myers Squibb Co. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 56. Bristol Myers Squibb Co. Recent Development
Table 57. Sanofi S.A. Company Details
Table 58. Sanofi S.A. Business Overview
Table 59. Sanofi S.A. Pain Therapeutic Solutions Product
Table 60. Sanofi S.A. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 61. Sanofi S.A. Recent Development
Table 62. Boehringer Ingelheim International GmbH Company Details
Table 63. Boehringer Ingelheim International GmbH Business Overview
Table 64. Boehringer Ingelheim International GmbH Pain Therapeutic Solutions Product
Table 65. Boehringer Ingelheim International GmbH Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 66. Boehringer Ingelheim International GmbH Recent Development
Table 67. Pfizer Inc. Company Details
Table 68. Pfizer Inc. Business Overview
Table 69. Pfizer Inc. Pain Therapeutic Solutions Product
Table 70. Pfizer Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 71. Pfizer Inc. Recent Development
Table 72. Cadila Pharmaceuticals Company Details
Table 73. Cadila Pharmaceuticals Business Overview
Table 74. Cadila Pharmaceuticals Pain Therapeutic Solutions Product
Table 75. Cadila Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 76. Cadila Pharmaceuticals Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Pain Therapeutic Solutions Product
Table 80. GSK Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Pain Therapeutic Solutions Product
Table 85. Abbott Laboratories Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 86. Abbott Laboratories Recent Development
Table 87. Novartis AG Company Details
Table 88. Novartis AG Business Overview
Table 89. Novartis AG Pain Therapeutic Solutions Product
Table 90. Novartis AG Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 91. Novartis AG Recent Development
Table 92. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
Table 93. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
Table 94. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pain Therapeutic Solutions Product
Table 95. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 96. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
Table 97. Sun Pharmaceutical Industries Ltd. Company Details
Table 98. Sun Pharmaceutical Industries Ltd. Business Overview
Table 99. Sun Pharmaceutical Industries Ltd. Pain Therapeutic Solutions Product
Table 100. Sun Pharmaceutical Industries Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 101. Sun Pharmaceutical Industries Ltd. Recent Development
Table 102. Teva Pharmaceuticals Ltd. Company Details
Table 103. Teva Pharmaceuticals Ltd. Business Overview
Table 104. Teva Pharmaceuticals Ltd. Pain Therapeutic Solutions Product
Table 105. Teva Pharmaceuticals Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 106. Teva Pharmaceuticals Ltd. Recent Development
Table 107. Mallinckrodt Pharmaceuticals Company Details
Table 108. Mallinckrodt Pharmaceuticals Business Overview
Table 109. Mallinckrodt Pharmaceuticals Pain Therapeutic Solutions Product
Table 110. Mallinckrodt Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 111. Mallinckrodt Pharmaceuticals Recent Development
Table 112. Endo Pharmaceuticals Inc. Company Details
Table 113. Endo Pharmaceuticals Inc. Business Overview
Table 114. Endo Pharmaceuticals Inc. Pain Therapeutic Solutions Product
Table 115. Endo Pharmaceuticals Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 116. Endo Pharmaceuticals Inc. Recent Development
Table 117. Bayer AG Company Details
Table 118. Bayer AG Business Overview
Table 119. Bayer AG Pain Therapeutic Solutions Product
Table 120. Bayer AG Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 121. Bayer AG Recent Development
Table 122. F. Hoffmann-La Roche Ltd. Company Details
Table 123. F. Hoffmann-La Roche Ltd. Business Overview
Table 124. F. Hoffmann-La Roche Ltd. Pain Therapeutic Solutions Product
Table 125. F. Hoffmann-La Roche Ltd. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 126. F. Hoffmann-La Roche Ltd. Recent Development
Table 127. Procter & Gamble Company Details
Table 128. Procter & Gamble Business Overview
Table 129. Procter & Gamble Pain Therapeutic Solutions Product
Table 130. Procter & Gamble Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 131. Procter & Gamble Recent Development
Table 132. AstraZeneca Company Details
Table 133. AstraZeneca Business Overview
Table 134. AstraZeneca Pain Therapeutic Solutions Product
Table 135. AstraZeneca Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 136. AstraZeneca Recent Development
Table 137. Cardinal Health Company Details
Table 138. Cardinal Health Business Overview
Table 139. Cardinal Health Pain Therapeutic Solutions Product
Table 140. Cardinal Health Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 141. Cardinal Health Recent Development
Table 142. Perrigo Company Plc. Company Details
Table 143. Perrigo Company Plc. Business Overview
Table 144. Perrigo Company Plc. Pain Therapeutic Solutions Product
Table 145. Perrigo Company Plc. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 146. Perrigo Company Plc. Recent Development
Table 147. Bausch Health Companies Inc. Company Details
Table 148. Bausch Health Companies Inc. Business Overview
Table 149. Bausch Health Companies Inc. Pain Therapeutic Solutions Product
Table 150. Bausch Health Companies Inc. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 151. Bausch Health Companies Inc. Recent Development
Table 152. Viatris Company Details
Table 153. Viatris Business Overview
Table 154. Viatris Pain Therapeutic Solutions Product
Table 155. Viatris Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 156. Viatris Recent Development
Table 157. Amneal Pharmaceuticals Company Details
Table 158. Amneal Pharmaceuticals Business Overview
Table 159. Amneal Pharmaceuticals Pain Therapeutic Solutions Product
Table 160. Amneal Pharmaceuticals Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 161. Amneal Pharmaceuticals Recent Development
Table 162. Purdue Pharmaceuticals L.P. Company Details
Table 163. Purdue Pharmaceuticals L.P. Business Overview
Table 164. Purdue Pharmaceuticals L.P. Pain Therapeutic Solutions Product
Table 165. Purdue Pharmaceuticals L.P. Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 166. Purdue Pharmaceuticals L.P. Recent Development
Table 167. Medtronic Company Details
Table 168. Medtronic Business Overview
Table 169. Medtronic Pain Therapeutic Solutions Product
Table 170. Medtronic Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 171. Medtronic Recent Development
Table 172. Boston Scientific Company Details
Table 173. Boston Scientific Business Overview
Table 174. Boston Scientific Pain Therapeutic Solutions Product
Table 175. Boston Scientific Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 176. Boston Scientific Recent Development
Table 177. Abbott Company Details
Table 178. Abbott Business Overview
Table 179. Abbott Pain Therapeutic Solutions Product
Table 180. Abbott Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 181. Abbott Recent Development
Table 182. OMRON Company Details
Table 183. OMRON Business Overview
Table 184. OMRON Pain Therapeutic Solutions Product
Table 185. OMRON Revenue in Pain Therapeutic Solutions Business (2020-2025) & (US$ Million)
Table 186. OMRON Recent Development
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. Authors List of This Report
List of Figures
Figure 1. Pain Therapeutic Solutions Picture
Figure 2. Global Pain Therapeutic Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pain Therapeutic Solutions Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Medical Devices Features
Figure 6. Others Features
Figure 7. Global Pain Therapeutic Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pain Therapeutic Solutions Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Drugstores Case Studies
Figure 11. Others Case Studies
Figure 12. Pain Therapeutic Solutions Report Years Considered
Figure 13. Global Pain Therapeutic Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pain Therapeutic Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pain Therapeutic Solutions Market Share by Region: 2024 VS 2031
Figure 16. Global Pain Therapeutic Solutions Market Share by Players in 2024
Figure 17. Global Pain Therapeutic Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Pain Therapeutic Solutions Revenue in 2024
Figure 19. North America Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pain Therapeutic Solutions Market Share by Country (2020-2031)
Figure 21. United States Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pain Therapeutic Solutions Market Share by Country (2020-2031)
Figure 25. Germany Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pain Therapeutic Solutions Market Share by Region (2020-2031)
Figure 33. China Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pain Therapeutic Solutions Market Share by Country (2020-2031)
Figure 41. Mexico Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pain Therapeutic Solutions Market Share by Country (2020-2031)
Figure 45. Israel Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pain Therapeutic Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. AbbVie Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 49. Bristol Myers Squibb Co. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 50. Sanofi S.A. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 51. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 52. Pfizer Inc. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 53. Cadila Pharmaceuticals Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 55. Abbott Laboratories Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 56. Novartis AG Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 57. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 58. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 59. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 60. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 61. Endo Pharmaceuticals Inc. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 62. Bayer AG Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 64. Procter & Gamble Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 65. AstraZeneca Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 66. Cardinal Health Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 67. Perrigo Company Plc. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 68. Bausch Health Companies Inc. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 69. Viatris Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 70. Amneal Pharmaceuticals Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 71. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 72. Medtronic Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 73. Boston Scientific Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 74. Abbott Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 75. OMRON Revenue Growth Rate in Pain Therapeutic Solutions Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
